New HSP90-CDC37 protein-protein interaction inhibitors with antitumor in vitro and in vivo efficacy Feb. 18, 2021
Small molecule targeting ER stress-responsive chaperones suppresses abnormal tau protein aggregation Feb. 17, 2021
Preclinical results of an ACE2-interacting domain of SARS-CoV-2 peptide for COVID-19 treatment Feb. 16, 2021
PW-0787, a novel potent and brain-penetrant GPR52 agonist for neuropsychiatric disorders Jan. 15, 2021
RSS